Katarina le Blanc

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

Professor i klinisk stamcellsforskning med fokus på mesenkymala stromaceller.

Artiklar

Article: STEM CELL RESEARCH AND THERAPY. 2024;15(1):77
Transcriptomic and proteomic profiles of fetal versus adult mesenchymal stromal cells and mesenchymal stromal cell-derived extracellular vesicles
Gencer EB; Lor YK; Abomaray F; El Andaloussi S; Pernemalm M; Sharma N; Hagey DW; Gorgens A; Gustafsson MO; Le Blanc K; Toonsi MA; Walther-Jallow L; Goetherstrom C
Article: ORAL DISEASES. 2023;29(8):3346-3359
Immunohistopathology of oral mucosal chronic graft-versus-host disease severity and duration
Tollemar V; Strom J; Tudzarovski N; Habel H; Legert KG; Heymann R; Warfvinge G; Le Blanc K; Sugars RV
Article: CYTOTHERAPY. 2023;25(9):956-966
Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire
Davies LC; Queckborner S; Jylha CE; Andren AT; Forshell TZP; Le Blanc K
Article: CYTOTHERAPY. 2023;25(8):803-807
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue-derived MSCs for research purposes
Viswanathan S; Le Blanc K; Ciccocioppo R; Dagher G; Filiano AJ; Galipeau J; Krampera M; Krieger L; Lalu MM; Nolta J; Pardo VMR; Shi Y; Tarte K; Weiss DJ; Martin I
Article: BLOOD. 2023;142(1):73-89
Characterization of the bone marrow niche in patients with chronic myeloid leukemia identifies CXCL14 as a new therapeutic option
Dolinska M; Cai H; Mansson A; Shen J; Xiao P; Bouderlique T; Li X; Leonard E; Chang M; Gao Y; Medina JP; Kondo M; Sandhow L; Johansson A-SF; Deneberg S; Soederlund S; Jaedersten M; Ungerstedt J; Tobiasson M; Ostman A; Mustjoki S; Stenke L; Le Blanc K; Hellstroem-Lindberg E; Lehmann S; Ekblom M; Olsson-Stroemberg U; Sigvarosson M; Qian H
Article: LEUKEMIA. 2023;37(4):888-900
Cognitive impairments correlate with increased central nervous system immune activation after allogeneic haematopoietic stem cell transplantation
Boberg E; Kadri N; Hagey DWW; Schwieler L; El Andaloussi S; Erhardt S; Iacobaeus E; Le Blanc K
Article: HELIYON. 2023;9(4):e15517
Grading of minor salivary gland immuno-histopathology post-allogenic hematopoietic cell transplantation
Tollemar V; Arvidsson H; Habel H; Tudzarovski N; Legert KG; Le Blanc K; Warfvinge G; Sugars RV
Journal article: BIOMATERIALS ADVANCES. 2023;147:213331
Biomimetic polyelectrolyte coating of stem cells suppresses thrombotic activation and enhances its survival and function
Rangasami VK; Asawa K; Teramura Y; Le Blanc K; Nilsson B; Varghese OP; Oommen OP
Article: METABOLISM OPEN. 2022;13:100167
Diversity of respiratory parameters and metabolic adaptation to low oxygen tension in mesenchymal stromal cells
Olesen K; Moruzzi N; Bulatovic I; Folmes C; Jeon R; Felldin U; Terzic A; Simonson OE; Le Blanc K; Osterholm C; Berggren P-O; Schiffer T; Rodin S; Tilevik A; Grinnemo K-H
Article: BONE MARROW TRANSPLANTATION. 2022;57(3):360-369
Reduced prefrontal cortex and sympathetic nervous system activity correlate with fatigue after aHSCT
Boberg E; Iacobaeus E; Greenfield MS; Wang Y; Msghina M; Le Blanc K
Article: CYTOTHERAPY. 2021;23(12):1060-1063
Consensus International Council for Commonality in Blood Banking Automation-International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin of mesenchymal stromal cells
Viswanathan S; Ciccocioppo R; Galipeau J; Krampera M; Le Blanc K; Martin I; Moriz K; Nolta J; Phinney DG; Shi Y; Szczepiorkowski ZM; Tarte K; Weiss DJ; Ashford P
Article: LANCET NEUROLOGY. 2021;20(11):917-929
Safety, tolerability, and activity of mesenchymal stem cells versus placebo in multiple sclerosis (MESEMS): a phase 2, randomised, double-blind crossover trial
Uccelli A; Laroni A; Ali R; Battaglia MA; Blinkenberg M; Brundin L; Clanet M; Fernandez O; Marriot J; Muraro P; Nabavi SM; Oliveri RS; Radue E; Tello CR; Schiavetti I; Sellner J; Sorensen PS; Sormani MP; Wuerfel JT; Freedman MS
Article: CYTOTHERAPY. 2021;23(5):368-372
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition
Galipeau J; Krampera M; Leblanc K; Nolta JA; Phinney DG; Shi Y; Tarte K; Viswanathan S; Martin I
Article: STEM CELLS AND DEVELOPMENT. 2021;30(3):119-127
The Coronavirus Pandemic: A Pitfall or a Fast Track for Validating Cell Therapy Products?
Khoury M; Ikonomou L; Dominici M; LeBlanc K; Levine BL; Weiss DJ
Article: CYTOTHERAPY. 2020;22(11):602-605
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential
Khoury M; Rocco PRM; Phinney DG; Krampera M; Martin I; Viswanathan S; Nolta JA; LeBlanc K; Galipeau J; Weiss DJ
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2020;9(10):1190-1202
Treatment of chronicGvHDwith mesenchymal stromal cells induces durable responses: A phaseIIstudy
Boberg E; von Bahr L; Afram G; Lindstrom C; Ljungman P; Heldring N; Petzelbauer P; Legert KG; Kadri N; Le Blanc K
Article: STEM CELL RESEARCH AND THERAPY. 2020;11(1):128
Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells-first phase I/II human clinical study
Hertegard S; Nagubothu SR; Malmstrom E; LeBlan K
Article: THE LARYNGOSCOPE. 2020;130(1):E21-E29
Mesenchymal Stromal Cells Modulate Tissue Repair Responses Within the Injured Vocal Fold
Nagubothu SR; Sugars RV; Tudzarovski N; Andren AT; Bottai M; Davies LC; Hertegard S; Le Blanc K
Article: JOURNAL OF CLINICAL MEDICINE. 2019;8(12):E2102-2102
Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis-A Phase I Study
Iacobaeus E; Kadri N; Lefsihane K; Boberg E; Gavin C; Andren AT; Lilja A; Brundin L; Le Blanc K
Article: STEM CELL RESEARCH AND THERAPY. 2019;10(1):334
Tissue immune profiles supporting response to mesenchymal stromal cell therapy in acute graft-versus-host disease-a gut feeling
Gavin C; Boberg E; Von Bahr L; Bottai M; Andren AT; Wernerson A; Davies LC; Sugars RV; Le Blanc K
Article: CYTOTHERAPY. 2019;21(10):1019-1024
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature
Viswanathan S; Shi Y; Galipeau J; Krampera M; Leblanc K; Martin I; Nolta J; Phinney DG; Sensebe L
Article: STEM CELLS AND DEVELOPMENT. 2019;28(17):1177-1190
Hyaluronan Hydrogels for the Local Delivery of Mesenchymal Stromal Cells to the Injured Vocal Fold
Hertegard S; Nagubothu SR; Malmstrom E; Strom CE; Tolf A; Davies LC; Le Blanc K
Journal article: CYTOTHERAPY. 2019;21(7):782-792
Manufacturing mesenchymal stromal cells for clinical applications: A survey of Good Manufacturing Practices at US academic centers
Phinney DG; Galipeau J; Krampera M; Le Blanc K; Martin I; Nolta J; Sensebe L; Shi Y; Viswanathan S; Poole B; Bockhold S
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2249
The Complement System Is Essential for the Phagocytosis of Mesenchymal Stromal Cells by Monocytes
Gavin C; Meinke S; Heldring N; Heck KA; Achour A; Iacobaeus E; Le Blanc K; Kadri N; Hoglund P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2018;24(11):2365-2370
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation
Trento C; Bernardo ME; Nagler A; Kuci S; Bornhaeuser M; Koehl U; Strunk D; Galleu A; Sanchez-Guijo F; Gaipa G; Introna M; Bukauskas A; Le Blanc K; Apperley J; Roelofs H; Van Campenhout A; Beguin Y; Kuball J; Lazzari L; Avanzini MA; Fibbe W; Chabannon C; Bonini C; Dazzi F
Article: CYTOMETRY. PART A : THE JOURNAL OF THE INTERNATIONAL SOCIETY FOR ANALYTICAL CYTOLOGY. 2018;93A(10):1051-1059
Quantitative chromogenic immunohistochemical image analysis in cellprofiler software
Tollemar V; Tudzarovski N; Boberg E; Andren AT; Al-Adili A; Le Blanc K; Legert KG; Bottai M; Warfvinge G; Sugars RV
Article: IMMUNOLOGY AND CELL BIOLOGY. 2018;96(8):820-830
Phenotypic and functional alterations of myeloid-derived suppressor cells during the disease course of multiple sclerosis
Iacobaeus E; Douagi I; Jitschin R; Marcusson-Stahl M; Andren AT; Gavin C; Lefsihane K; Davies LC; Mougiakakos D; Kadri N; Le Blanc K
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2018;101(5):676-683
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision model
Thielen FW; Blommestein HM; Oosten LEM; Calkoen FG; Lankester AC; Zwaginga JJ; Le Blanc K; Redondo A; Sanchez-Guijo F; Algeri M; Locatelli F; Fibbe WE; Uyl-de Groot CA
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2017;6(10):1840-1851
Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and Demyelination
Iacobaeus E; Sugars RV; Andren AT; Alm JJ; Qian H; Frantzen J; Newcombe J; Alkass K; Druid H; Bottai M; Roytta M; Le Blanc K
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(4):677-683
Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions
Torlen J; Remberger M; Le Blanc K; Ljungman P; Mattsson J
Article: HAEMATOLOGICA. 2017;102(3):498-508
Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations
Scharenberg C; Giai V; Pellagatti A; Saft L; Dimitriou M; Jansson M; Jadersten M; Grandien A; Douagi I; Neuberg DS; LeBlanc K; Boultwood J; Karimi M; Jacobsen SEW; Woll PS; Hellstrom-Lindberg E
Article: STEM CELLS. 2017;35(3):766-776
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
Davies LC; Heldring N; Kadri N; Le Blanc K
Journal article: BLOOD. 2016;128(22):4329
Progression in Patients with with Low- and Intermediate-1 Risk Del(5q) MDS Is Predicted By a Limited Subset of Mutations
Scharenberg C; Woll PS; Giai V; Pellagatti A; Saft L; Dimitriou M; Jädersten M; Jansson M; Douagi I; Neuberg DS; Karimi M; Le Blanc K; Boultwood J; Jacobsen SE; Hellstrom-Lindberg E
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2016;5(11):1485-1495
Type 1 Diabetes Mellitus Donor Mesenchymal. Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro
Davies LC; Alm JJ; Heldring N; Moll G; Gavin C; Batsis I; Qian H; Sigvardsson M; Nilsson B; Kyllonen LE; Salmela KT; Carlsson P-O; Korsgren O; Le Blanc K
Article: CLINICAL CANCER RESEARCH. 2016;22(15):3849-3859
Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma
Mao Y; Eissler N; Le Blanc K; Johnsen JI; Kogner P; Kiessling R
Article: SCIENTIFIC REPORTS. 2016;6:29160
MSC from fetal and adult lungs possess lung-specific properties compared to bone marrow-derived MSC
Enes SR; Sjoland AA; Skog I; Hansson L; Larsson H; Le Blanc K; Eriksson L; Bjermer L; Scheding S; Westergren-Thorsson G
Article: ACTA BIOMATERIALIA. 2016;35:194-205
Heparinization of cell surfaces with short peptide-conjugated PEG-lipid regulates thromboinflammation in transplantation of human MSCs and hepatocytes
Asif S; Ekdahl KN; Fromell K; Gustafson E; Barbu A; Le Blanc K; Nilsson B; Teramura Y
Article: STEM CELL REPORTS. 2016;6(4):607-617
Wnt/β-Catenin Stimulation and Laminins Support Cardiovascular Cell Progenitor Expansion from Human Fetal Cardiac Mesenchymal Stromal Cells
Mansson-Broberg A; Rodin S; Bulatovic I; Ibarra C; Lofling M; Genead R; Wardell E; Felldin U; Granath C; Alici E; Le Blanc K; Smith CIE; Salasova A; Westgren M; Sundstrom E; Uhlen P; Arenas E; Sylven C; Tryggvason K; Corbascio M; Simonson OE; Osterholm C; Grinnemo K-H
Journal article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):s178
Community Acquired Respiratory Viral Infections (CARV) in Patients with Acute Leukemia and Hematopoietic Stem Cell Transplant (HSCT) Recipients
Trikha G; Hiemenz J; Wingard JR; Zou F; LeBlanc K; Mattsson J; Ljungman PT
Article: CYTOTHERAPY. 2016;18(2):151-159
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Galipeau J; Krampera M; Barrett J; Dazzi F; Deans RJ; Debruijn J; Dominici M; Fibbe WE; Gee AP; Gimble JM; Hematti P; Koh MBC; Leblanc K; Martin I; McNiece IK; Mendicino M; Oh S; Ortiz L; Phinney DG; Planat V; Shi Y; Stroncek DF; Viswanathan S; Weiss DJ; Sensebe L
Article: STEM CELLS. 2016;34(2):516-521
Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation
Boettcher M; Hofmann AD; Bruns H; Haibach M; Loschinski R; Saul D; Mackensen A; Le Blanc K; Jitschin R; Mougiakakos D
Journal article: BLOOD. 2015;126(23):3138
Treatment of Chronic GvHD with Mesenchymal Stromal Cells Induces Durable Responses; A Phase II Study
Von Bahr L; Davies L; Afram G; Modin C; Garming-Legert K; Hagglund H; Ljungman PT; Le Blanc K
Article: IMMUNOLOGY LETTERS. 2015;168(2):140-146
Mesenchymal stromal cells and the innate immune response
Le Blanc K; Davies LC
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2015;4(10):1199-1213
In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome
Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalen M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OPB; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson P-O; Haegglund H; Mattsson M; Lentio J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo K-H; Le Blanc K
Article: BONE MARROW TRANSPLANTATION. 2015;50(9):1217-1223
Increased incidence of chronic GvHD and CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
von Bahr L; Blennow O; Alm J; Bjorklund A; Malmberg K-J; Mougiakakos D; Le Blanc A; Oefner PJ; Labopin M; Ljungman P; Le Blanc K
Article: CURRENT DIABETES REPORTS. 2015;15(7):46
Mesenchymal Stromal Cells to Halt the Progression of Type 1 Diabetes?
Carlsson P-O; Korsgren O; Le Blanc K
Article: STEM CELLS AND DEVELOPMENT. 2015;24(12):1405-1414
Amniotic Fluid-A Source for Clinical Therapeutics in the Newborn?
Ekblad A; Qian H; Westgren M; Le Blanc K; Fossum M; Gotherstrom C
Article: TRANSPLANT INFECTIOUS DISEASE. 2015;17(3):371-379
Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients
Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
Article: BLOOD. 2015;125(22):3432-3436
Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling
Jitschin R; Braun M; Qorraj M; Saul D; Le Blanc K; Zenz T; Mougiakakos D
Journal article: ISBT SCIENCE SERIES. 2015;10(S1):357-365
Engineering more efficient multipotent mesenchymal stromal (stem) cells for systemic delivery as cellular therapy
Moll G; Le Blanc K
Article: DIABETES. 2015;64(2):587-592
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
Carlsson P-O; Schwarcz E; Korsgren O; Le Blanc K
Article: BONE MARROW TRANSPLANTATION. 2015;50(2):173-180
SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking
Alexander T; Bondanza A; Muraro PA; Greco R; Saccardi R; Daikeler T; Kazmi M; Hawkey C; Simoes P; Leblanc K; Fibbe WE; Moore J; Snarski E; Martin T; Hiepe F; Velardi A; Toubert A; Snowden JA; Farge D
Article: REGENERATIVE MEDICINE RESEARCH. 2015;3:1
Mesenchymal stromal cells support endothelial cell interactions in an intramuscular islet transplantation model.
Fransson M; Brännström J; Duprez I; Essand M; Le Blanc K; Korsgren O; Magnusson PU
Article: JOURNAL OF EXTRACELLULAR VESICLES. 2015;4:26316
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting.
Wiklander OPB; Nordin JZ; O'Loughlin A; Gustafsson Y; Corso G; Mäger I; Vader P; Lee Y; Sork H; Seow Y; Heldring N; Alvarez-Erviti L; Smith CIE; Le Blanc K; Macchiarini P; Jungebluth P; Wood MJA; Andaloussi SE
Journal article: REGENERATIVE MEDICINE. 2015;10(7 Suppl):s96-s296
Poster Presentations.
Article: TISSUE ENGINEERING - PART A.. 2014;20(19-20):2549-2554
White Paper on How to Go Forward with Cell-Based Advanced Therapies in Europe
Erben RG; Silva-Lima B; Reischl I; Steinhoff G; Tiedemann G; Dalemans W; Vos A; Janssen RTA; Le Blanc K; van Osch GJVM; Luyten FP
Article: STEM CELLS. 2014;32(9):2430-2442
Do Cryopreserved Mesenchymal Stromal Cells Display Impaired Immunomodulatory and Therapeutic Properties?
Moll G; Alm JJ; Davies LC; von Bahr L; Heldring N; Stenbeck-Funke L; Hamad OA; Hinsch R; Ignatowicz L; Locke M; Lonnies H; Lambris JD; Teramura Y; Nilsson-Ekdahl K; Nilsson B; Le Blanc K
Article: BLOOD. 2014;124(5):750-760
CLL-cells induce IDO^hi CD14⁺HLA-DR^lo myeloid-derived suppressor cells that inhibit T-cell responses and promote T_Regs
Jitschin R; Braun M; Buettner M; Dettmer-Wilde K; Bricks J; Berger J; Eckart MJ; Krause SW; Oefner PJ; Le Blanc K; Mackensen A; Mougiakakos D
Article: CYTOTHERAPY. 2014;16(7):915-926
Defined serum-free media for in vitro expansion of adipose-derived mesenchymal stem cells
Al-Saqi SH; Saliem M; Asikainen S; Quezada HC; Ekslad A; Hovatta O; Le Blanc K; Jonasson AF; Gotherstrom C
Article: IMMUNOLOGY. 2014;142(3):431-441
Intranasal delivery of central nervous system-retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis
Fransson M; Piras E; Wang H; Burman J; Duprez I; Harris RA; LeBlanc K; Magnusson PU; Brittebo E; Loskog ASI
Article: STEM CELLS TRANSLATIONAL MEDICINE. 2014;3(2):255-264
Pre- and Postnatal Transplantation of Fetal Mesenchymal Stem Cells in Osteogenesis Imperfecta: A Two-Center Experience
Gotherstrom C; Westgren M; Shaw SWS; Astrom E; Biswas A; Byers PH; Mattar CNZ; Graham GE; Taslimi J; Ewald U; Fisk NM; Yeoh AEJ; Lin J-L; Cheng P-J; Choolani M; Le Blanc K; Chan JKY
Article: PLOS ONE. 2014;9(1):e85040
Do ABO Blood Group Antigens Hamper the Therapeutic Efficacy of Mesenchymal Stromal Cells?
Moll G; Hult A; von Bahr L; Alm JJ; Heldring N; Hamad OA; Stenbeck-Funke L; Larsson S; Teramura Y; Roelofs H; Nilsson B; Fibbe WE; Olsson ML; Le Blanc K
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2013;163(4):501-509
Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease
Ball LM; Bernardo ME; Roelofs H; van Tol MJD; Contoli B; Zwaginga JJ; Avanzini MA; Conforti A; Bertaina A; Giorgiani G; Jol-van der Zijde CM; Zecca M; Le Blanc K; Frassoni F; Egeler RM; Fibbe WE; Lankester AC; Locatelli F
Article: STEM CELLS. 2013;31(8):1715-1725
Alterations in the Cellular Immune Compartment of Patients Treated with Third-Party Mesenchymal Stromal Cells Following Allogeneic Hematopoietic Stem Cell Transplantation
Jitschin R; Mougiakakos D; Von Bahr L; Voelkl S; Moll G; Ringden O; Kiessling R; Linder S; Le Blanc K
Article: JOURNAL OF INTERNAL MEDICINE. 2013;274(2):153-162
A prospective randomized toxicity study to compare reduced-intensity and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Ringden O; Erkers T; Aschan J; Garming-Legert K; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Dahllof G; Mattsson J; Ljungman P; Remberger M
Article: ONCOIMMUNOLOGY. 2013;2(7):e25009
Myeloid-derived suppressor cells in allogeneic hematopoietic stem cell transplantation A double-edged sword?
Le Blanc K; Jitschin R; Mougiakakos D
Article: LEUKEMIA. 2013;27(2):377-388
Immunosuppressive CD14⁺HLA-DR^low/neg IDO⁺ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
Mougiakakos D; Jitschin R; von Bahr L; Poschke I; Gary R; Sundberg B; Gerbitz A; Ljungman P; Le Blanc K
Article: PLOS ONE. 2013;8(1):e55319
Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSCs) Engraft In Vivo and Support Hematopoiesis without Suppressing Immune Function: Implications for Off-The Shelf ES-MSC Therapies
Li O; Tormin A; Sundberg B; Hyllner J; Le Blanc K; Scheding S
Article: PLOS ONE. 2013;8(1):e54952
Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
Yu D; Jin C; Ramachandran M; Xu J; Nilsson B; Korsgren O; Le Blanc K; Uhrbom L; Forsberg-Nilsson K; Westermark B; Adamson R; Maitland N; Fan X; Essand M
Article: MEDICAL ONCOLOGY. 2012;29(4):2348-2358
Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution
Nahi H; Remberger M; Machaczka M; Ungerstedt J; Mattson J; Ringden O; Le-Blanc K; Ljungman P; Hagglund H
Article: TRANSPLANTATION. 2012;94(10):1066-1074
Factors With an Impact on Chimerism Development and Long-Term Survival After Umbilical Cord Blood Transplantation
Berglund S; Le Blanc K; Remberger M; Gertow J; Uzunel M; Svenberg P; Winiarski J; Ljungman P; Ringden O; Uhlin M; Mattsson J
Article: STEM CELLS AND DEVELOPMENT. 2012;21(17):3147-3151
Treatment of Familial Hemophagocytic Lymphohistiocytosis with Third-Party Mesenchymal Stromal Cells
Mougiakakos D; Machaczka M; Jitschin R; Klimkowska M; Entesarian M; Bryceson YT; Henter J-I; Sander B; Le Blanc K
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2012;89(3):220-227
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation
Forslow U; Blennow O; LeBlanc K; Ringden O; Gustafsson B; Mattsson J; Remberger M
Article: PEDIATRIC TRANSPLANTATION. 2012;16(6):E241-E245
Donor cell-derived acute myeloid leukemia after second allogenic cord blood transplantation in a patient with Fanconi anemia
Gustafsson B; Moell J; LeBlanc K; Barbany G; Soderhall S; Winiarski J
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2012;287(31):25795-25807
Primary Mesenchymal Stem and Progenitor Cells from Bone Marrow Lack Expression of CD44 Protein
Qian H; Le Blanc K; Sigvardsson M
Article: STEM CELLS. 2012;30(7):1575-1578
Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
von Bahr L; Batsis I; Moll G; Hagg M; Szakos A; Sundberg B; Uzunel M; Ringden O; Le Blanc K
Article: STEM CELLS. 2012;30(7):1565-1574
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Moll G; Rasmusson-Duprez I; von Bahr L; Connolly-andersen A-M; Elgue G; Funke L; Hamad OA; Lonnies H; Magnusson PU; Sanchez J; Teramura Y; Nilsson-Ekdahl K; Ringden O; Korsgren O; Nilsson B; Le Blanc K
Article: STEM CELLS AND DEVELOPMENT. 2012;21(9):1478-1487
Oral Mucosal Progenitor Cells Are Potently Immunosuppressive in a Dose-Independent Manner
Davies LC; Lonnies H; Locke M; Sundberg B; Rosendahl K; Gotherstrom C; Le Blanc K; Stephens P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(4):557-564
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
von Bahr L; Sundberg B; Lonnies L; Sander B; Karbach H; Hagglund H; Ljungman P; Gustafsson B; Karlsson H; Le Blanc K; Ringden O
Article: TISSUE ENGINEERING - PART B: REVIEWS. 2012;18(2):101-115
Therapeutic Applications of Mesenchymal Stromal Cells: Paracrine Effects and Potential Improvements
Doorn J; Moll G; Le Blanc K; van Blitterswijk C; de Boer J
Article: CELL TRANSPLANTATION. 2012;21(1):333-343
Targeted Intra-arterial Transplantation of Stem Cells to the Injured CNS Is More Effective Than Intravenous Administration: Engraftment Is Dependent on Cell Type and Adhesion Molecule Expression
Lundberg J; Sodersten E; Sundstrom E; Le Blanc K; Andersson T; Hermanson O; Holmin S
Journal article: THE LANCET. 2011;378(9808):1997-2004
Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study (Publication with Expression of Concern. See vol. 387, pg. 1359, 2016) (Retracted article. See vol. 392, pg. 11, 2018)
Jungebluth P; Alici E; Baiguera S; Le Blanc K; Blomberg P; Bozoky B; Crowley C; Einarsson O; Grinnemo K-H; Gudbjartsson T; Le Guyader S; Henriksson G; Hermanson O; Juto JE; Leidner B; Lilja T; Liska J; Luedde T; Lundin V; Moll G; Nilsson B; Roderburg C; Stromblad S; Sutlu T; Teixeira AI; Watz E; Seifalian A; Macchiarini P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2011;17(11):1688-1697
Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study
Remberger M; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Malmberg K-J; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Ringden O
Article: THE LARYNGOSCOPE. 2011;121(10):2185-2190
Injection of Human Mesenchymal Stem Cells Improves Healing of Vocal Folds after Scar Excision-A Xenograft Analysis
Svensson B; Nagubothu SR; Cedervall J; Chan RW; Le Blanc K; Kimura M; Ahrlund-Richter L; Tolf A; Hertegard S
Article: BLOOD. 2011;117(18):4826-4835
The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells
Mougiakakos D; Jitschin R; Johansson CC; Okita R; Kiessling R; Le Blanc K
Article: JOURNAL OF IMMUNOTHERAPY. 2011;34(4):336-342
Multipotent Mesenchymal Stromal Cells Express FoxP3: A Marker for the Immunosuppressive Capacity?
Sundin M; D'Arcy P; Johansson CC; Barrett AJ; Loennies H; Sundberg B; Nava S; Kiessling R; Mougiakakos D; Le Blanc K
Article: CYTOTHERAPY. 2011;13(3):269-278
Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways
Gotherstrom C; Lundqvist A; Duprez IR; Childs R; Berg L; le Blanc K
Article: BEST PRACTICE AND RESEARCH: CLINICAL HAEMATOLOGY. 2011;24(1):65-72
Mesenchymal stem cells for treatment of acute and chronic graft-versus-host disease, tissue toxicity and hemorrhages
Ringden O; Le Blanc K
Article: BONE MARROW TRANSPLANTATION. 2011;46(2):200-207
Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation
Bernardo ME; Ball LM; Cometa AM; Roelofs H; Zecca M; Avanzini MA; Bertaina A; Vinti L; Lankester A; Maccario R; Ringden O; Le Blanc K; Egeler RM; Fibbe WE; Locatelli F
Article: PLOS ONE. 2011;6(7):e21703
Mesenchymal Stromal Cells Engage Complement and Complement Receptor Bearing Innate Effector Cells to Modulate Immune Responses
Moll G; Jitschin R; von Bahr L; Rasmusson-Duprez I; Sundberg B; Lonnies L; Elgue G; Nilsson-Ekdahl K; Mougiakakos D; Lambris JD; Ringden O; Le Blanc K; Nilsson B
Journal article: BLOOD. 2010;116(21):2336
Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome
Ball LM; Bernardo ME; Zwaginga JJ; van Tol M; Cometa A; Roelofs H; Giorgiani G; der Zijde CMJ-V; Avanzini MA; Le Blanc K; Bertaina A; Frassoni F; Fibbe WE; Ringden O; Egeler RM; Locatelli F; Lankester A
Journal article: BLOOD. 2010;116(21):3858
Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune-Modulatory Function. Implications for off-the Shelf ES-MSC Therapies.
Li O; Tormin A; Brune JC; Sundberg B; Hyllner J; Le Blanc K; Scheding S
Journal article: ULTRASOUND IN OBSTETRICS AND GYNECOLOGY. 2010;36(S1):132
OP27.07: Intrauterine transfusion (IUT) of mesenchymal stem cells in two fetuses with fractures: follow‐up to 3 and 4 years of age
Yamamoto M; Conget P; Anguita T; Allers C; Testart E; Castillo S; Gothestrom C; Le Blanc K; Crain C; Insunza A
Article: CYTOTHERAPY. 2010;12(5):576-578
Defining the risks of mesenchymal stromal cell therapy
Prockop DJ; Brenner M; Fibbe WE; Horwitz E; Le Blanc K; Phinney DG; Simmons PJ; Sensebe L; Keating A
Article: THE LARYNGOSCOPE. 2010;120(7):1370-1375
Injection of Human Mesenchymal Stem Cells Improves Healing of Scarred Vocal Folds: Analysis Using a Xenograft Model
Svensson B; Nagubothu RS; Cedervall J; Le Blanc K; Ahrlund-Richter L; Tolf A; Hertegard S
Journal article: BLOOD. 2009;114(22):4580
Human Mesenchymal Stem Cells Elicit Complement Activation in Human Blood.
Le Blanc K; Moll G; Rasmusson I; Ekdahl KN; Elgue G; Sundberg B; Nilsson B
Article: NEURORADIOLOGY. 2009;51(10):661-667
Endovascular transplantation of stem cells to the injured rat CNS
Lundberg J; Le Blanc K; Soderman M; Andersson T; Holmin S
Article: TRANSPLANT INFECTIOUS DISEASE. 2009;11(5):393-399
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction
Omar H; Hagglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(9):1108-1115
Lymphocyte Recovery Is a Major Determinant of Outcome after Matched Unrelated Myeloablative Transplantation for Myelogenous Malignancies
Le Blanc K; Barrett AJ; Schaffer M; Hagglund H; Ljungman P; Ringden O; Remberger M
Article: JOURNAL OF IMMUNOTHERAPY. 2009;32(7):755-764
HSCT Recipients Have Specific Tolerance to MSC but not to the MSC Donor
Sundin M; Barrett AJ; Ringden O; Uzunel M; Lonnies H; Dackland A-L; Christensson B; Le Blanc K
Article: CYTOTHERAPY. 2009;11(2):129-136
Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells
Samuelsson H; Ringden O; Lonnies H; Le Blanc K
Journal article: CYTOTHERAPY. 2009;11(6):674-675
Hematopoiesis does not always get support from MSC
Le Blanc K
Journal article: BLOOD. 2008;112(11):4745
Persistence of Human Parvovirus B19 in Multipotent Mesenchymal Stromal Cells Expressing the Erythrocyte P antigen: Implications for Transplantation
Sundin M; Lindblom A; Örvell C; Barrett AJ; Sundberg B; Watz E; Wikman A; Broliden K; Le Blanc K
Journal article: BLOOD. 2008;112(11):4740
HLA Mismatched MSC Suppress T Lymphocyte Allo responses in Vitro and Do Not Induce Immunological Memory in Recipients of MSC Infusion
Sundin M; Barrett AJ; Ringdén O; Uzunel M; Lönnies H; Dackland Å-L; Christensson B; Le Blanc K
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(10):1172-1179
Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen:: Implications for transplantation
Sundin M; Lindblom A; Orvell C; Barrett AJ; Sundberg B; Watz E; Wikman A; Broliden K; Le Blanc K
Article: BLOOD. 2008;112(3):532-541
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
Karlsson H; Samarasinghe S; Ball LM; Sundberg B; Lankester AC; Dazzi F; Uzunel M; Rao K; Veys P; Le Blanc K; Ringden O; Amrolia PJ
Article: BEST PRACTICE AND RESEARCH: CLINICAL HAEMATOLOGY. 2008;21(2):165-176
Prophylaxis of acute GVHD: manipulate the graft or the environment?
Barrett AJ; Le Blanc K
Article: THE LANCET. 2008;371(9624):1579-1586
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
LeBlanc K; Frassoni F; Ball L; Locatelli F; Roelofs H; Lewis I; Lanino E; Sundberg B; Bernardo ME; Remberger M; Dini G; Egeler RM; Bacigalupo A; Fibbe W; Ringden O
Article: BONE MARROW TRANSPLANTATION. 2008;41(4):399-405
Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors -: a single centre study
Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringden O
Article: CYTOTHERAPY. 2008;10(3):238-242
No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells
Sundin M; Remberger M; Lonnies H; Sundberg B; Ringden O; Le Blanc K
Article: CYTOTHERAPY. 2008;10(2):174-181
In vitro immunologic properties of human umbilical cord perivascular cells
Ennis J; Gotherstrom C; Le Blanc K; Davies JE
Article: LEUKEMIA. 2007;21(11):2271-2276
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon
Ringden O; Uzunel M; Sundberg B; Lonnies L; Nava S; Gustafsson J; Henningsohn L; Le Blanc K
Article: TRANSPLANTATION. 2007;84(8):1055-1059
Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum
Le Blanc K; Samuelsson H; Lönnies L; Sundin M; Ringdén O
Article: JOURNAL OF LEUKOCYTE BIOLOGY. 2007;82(4):887-893
Mesenchymal stem cells fail to trigger effector functions of cytotoxic T lymphocytes
Rasmusson I; Uhlin M; Le Blanc K; Levitsky V
Article: CLINICAL TRANSPLANTATION. 2007;21(5):659-667
Hemorrhagic cystitis:: a retrospective single-center survey
Hassan Z; Remberger M; Svenberg P; Elbander M; Omazic B; Mattsson J; Conrad R; Svahn B-M; Ahlgren A; Sairafi D; Aschan J; Le Blanc K; Barkholt L; Ringden O
Article: HAEMATOLOGICA. 2007;92(9):1208-1215
No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients
Sundin M; Ringden O; Sundberg B; Nava S; Gotherstrom C; Le Blanc K
Article: LEUKEMIA. 2007;21(8):1733-1738
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells
Le Blanc K; Samuelsson H; Gustafsson B; Remberger M; Sundberg B; Arvidson J; Ljungman P; Lonnies H; Nava S; Ringden O
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2007;65(4):336-343
Mesenchymal stem cells stimulate antibody secretion in human B cells
Rasmusson I; Le Blanc K; Sundberg B; Ringden O
Journal article: BLOOD. 2006;108(11):5304
Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
Le Blanc K; Frassoni F; Ball L; Lanino E; Sundberg B; Lonnies L; Roelofs H; Dini G; Bacigalupo A; Locatelli F; Fibbe WF; Ringden O
Journal article: BLOOD. 2006;108(11):2918
Mesenchymal Stem Cells for Treatment of Severe Acute Graft-Versus-Host Disease.
Le Blanc K; Frassoni F; Ball L; Lanino E; Sundberg B; Lonnies H; Roelofs H; Dini G; Bacigalupo A; Locatelli F; Fibbe WF; Ringden O
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2006;135(3):367-373
Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens
Merup M; Lazarevic V; Nahi H; Andreasson B; Malm C; Nilsson L; Brune M; LeBlanc K; Kutti J; Birgegard G
Article: ARTHRITIS & RHEUMATOLOGY. 2006;55(4):521-525
Stem cells and rheumatology: Update on adult stem cell therapy in autoimmune diseases
Tyndall A; Leblanc K
Article: HAEMATOLOGICA. 2006;91(8):1059-1067
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation
Sundin M; Le Blanc K; Ringden O; Barkholt L; Omazic B; Lergin C; Levitsky V; Remberger M
Article: THE LARYNGOSCOPE. 2006;116(7):1248-1254
Viscoelastic and histologic properties in scarred rabbit vocal folds after mesenchymal stem cell injection
Hertegard S; Cedervall J; Svensson B; Forsberg K; Maurer FHJ; Vidovska D; Olivius P; Ahrlund-Richter L; Le Blanc K
Article: BONE MARROW TRANSPLANTATION. 2006;37(11):1051-1059
Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual
Sundin M; Orvell C; Rasmusson I; Sundberg B; Ringden O; Le Blanc K
Article: TRANSPLANTATION. 2006;81(10):1390-1397
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease
Ringden O; Uzunel M; Rasmusson I; Remberger M; Sundberg B; Lonnies H; Marschall H-U; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Article: TRANSPLANTATION. 2006;81(5):718-725
Allogeneic hematopoietic stem cell transplantation for inherited disorders:: Experience in a single center
Ringdén O; Remberger M; Svahn BM; Barkholt L; Mattsson J; Aschan J; Le Blanc K; Gustafsson B; Hassan Z; Omazic B; Svenberg P; Solders G; von Döbeln U; Winiarski J; Ljungman P; Malm G
Article: ANNALS OF MEDICINE. 2006;38(2):144-153
Human mesenchymal stem cells do not differentiate into cardiomyocytes in a cardiac ischemic xenomodel
Grinnemo KH; Månsson-Broberg A; Leblanc K; Corbascio M; Wärdell E; Siddiqui AJ; Hao XJ; Sylvén C; Dellgren G
Article: CYTOTHERAPY. 2006;8(4):315-317
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement
Dominici M; Le Blanc K; Mueller I; Slaper-Cortenbach I; Marini FC; Krause DS; Deans RJ; Keating A; Prockop DJ; Horwitz EM
Article: CYTOTHERAPY. 2006;8(6):559-561
Mesenchymal stromal cells: tissue repair and immune modulation
Le Blanc K
Article: INTERNATIONAL JOURNAL OF OBESITY. 2005;29(12):1413-1421
Differential function of the α2A-adrenoceptor and phosphodiesterase-3B in human adipocytes of different origin
Dicker A; Kaaman M; van Harmelen V; Åström G; Blanc KL; Rydén M
Journal article: BLOOD. 2005;106(11):143
Mesenchymal Stem Cells for Treatment of Severe Acute and Extensive Chronic Graft-Versus-Host Disease.
Le Blanc K; Frassoni F; Ball L; Uzunel M; Lanini E; Sundberg B; Lonnies H; Dini G; Bacigalupo A; Locatelli F; Fibbe WE; Ringden OTH
Journal article: BLOOD. 2005;106(11):2911
Transplantation of Haplo-Identical Bone Marrow-Derived Mesenchymal Stem Cells Together with Hematopoietic Stem Cells To Promote Engraftment in Children. A Phase I/II Multicenter Study.
van Velzen-Ball LM; Le Blanc K; Lankester AC; Roelofs H; Egeler M; Frassoni F; Ringdén O; Fibbe WE
Article: EXPERIMENTAL CELL RESEARCH. 2005;308(2):283-290
Functional studies of mesenchymal stem cells derived from adult human adipose tissue
Dicker A; Le Blanc K; Åström G; van Harmelen V; Götherström C; Blomqvist L; Arner P; Rydén M
Article: HAEMATOLOGICA. 2005;90(8):1017-1026
Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells
Gotherstrom C; West A; Liden J; Uzunel M; Lahesmaa R; Le Blanc K
Article: TRANSPLANTATION. 2005;79(11):1607-1614
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta
Le Blanc K; Götherström C; Ringdén O; Hassan M; McMahon R; Horwitz E; Anneren G; Axelsson O; Nunn J; Ewald U; Nordén-Lindeberg S; Jansson M; Dalton A; Åström E; Westgren M
Article: EXPERIMENTAL CELL RESEARCH. 2005;305(1):33-41
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms
Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
Article: CANCER RESEARCH. 2005;65(6):2207-2215
Cancer/testis antigen expression in human mesenchymal stem cells:: Down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression
Cronwright G; Le Blanc K; Götherström C; Darcy P; Ehnman M; Brodin B
Article: CYTOTHERAPY. 2005;7(1):36-45
Mesenchymal stem cells: progress toward promise
Le Blanc K; Pittenger MF
Article: CYTOTHERAPY. 2005;7(5):393-395
Clarification of the nomenclature for MSC: The international society for cellular therapy position statement
Horwitz EM; Le Blanc K; Dominici M; Mueller I; Slaper-Cortenbach I; Marini FC; Deans RJ; Krause DS; Keating A
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(12):877-882
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors
Svenberg P; Remberger M; Svennilson J; Mattsson J; Leblanc K; Gustafsson B; Aschan J; Barkholt L; Winiarski J; Ljungman P; Ringdén O
Article: TRANSPLANTATION. 2004;78(7):1014-1020
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation
Le Blanc K; Remberger M; Uzunel M; Mansson J; Barkholt L; Ringdén O
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2004;60(3):307-315
Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes
Le Blanc K; Rasmusson I; Götherström C; Seidel C; Sundberg B; Sundin M; Rosendahl K; Tammik C; Ringdén O
Journal article: BONE MARROW TRANSPLANTATION. 2004;33(11):1167
Erratum: Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells
Götherström C; Ringdén O; Westgren M; Tammik C; Le Blanc K
Article: JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY. 2004;127(5):1293-1300
Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium
Grinnemo KH; Månsson A; Dellgren G; Klingberg D; Wardell E; Drvota V; Tammik C; Holgersson J; Ringdén O; Sylvén C; Le Blanc K
Article: THE LANCET. 2004;363(9419):1439-1441
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
Le Blanc K; Rasmusson I; Sundberg B; Götherström C; Hassan M; Uzunel M; Ringdén O
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(3):195-203
Graft-versus-Host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia
Nordlander A; Mattsson J; Ringdén O; Leblanc K; Gustafsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(2):128-134
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and-DRB1 genomically identical volunteers?
Ringdén O; Schaffer M; Le Blanc AA; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2004;22(3):416-423
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death:: A study from the acute leukemia working party of the European Group for Blood and Marrow Transplantation
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
Article: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2004;190(1):239-245
Immunologic properties of human fetal mesenchymal stem cells
Götherström C; Ringdén O; Tammik C; Zetterberg E; Westgren M; Le Blanc K
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2003;311(2):391-397
Functional characterization of human mesenchymal stem cell-derived adipocytes
Rydén M; Dicker A; Götherström C; Åström G; Tammik C; Arner P; Le Blanc K
Article: TRANSPLANTATION. 2003;76(8):1208-1213
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
Rasmusson I; Ringdén O; Sundberg B; Le Blanc K
Article: EXPERIMENTAL HEMATOLOGY. 2003;31(10):890-896
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells
Le Blanc K; Tammik C; Rosendahl K; Zetterberg E; Ringdén O
Article: HAEMATOLOGICA. 2003;88(9):1044-1052
A low body mass index is correlated with poor survival after allogeneic stem cell transplantation
Le Blanc K; Ringdén O; Remberger M
Article: BONE MARROW TRANSPLANTATION. 2003;32(3):265-272
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells
Götherström C; Ringdén O; Westgren M; Tammik C; Le Blanc K
Article: BONE MARROW TRANSPLANTATION. 2003;32(2):217-223
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV
Remberger M; Naseh N; Aschan J; Barkholt L; LeBlanc K; Svennberg P; Ringdén O
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2003;57(1):11-20
Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex
Le Blanc K; Tammik L; Sundberg B; Haynesworth SE; Ringdén O
Article: CYTOTHERAPY. 2003;5(6):485-489
Immunomodulatory effects of fetal and adult mesenchymal stem cells
Le Blanc K
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2000;65(5):322-330
Defective platelet aggregation in polycythaemia vera is not caused by impaired calcium signaling, phospholipase D activation or decreased amounts of focal adhesion proteins
Le Blanc K; Berg A; Palmblad J; Samuelsson J
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2000;108(1):80-85
Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythaemia vera
Le Blanc K; Andersson P; Samuelsson J
Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1997;59(5):310-317
No evidence for an altered mRNA expression or protein level of haematopoietic cell phosphatase in CD34(+) bone marrow progenitor cells or mature peripheral blood cells in polycythaemia vera
Andersson P; LeBlanc K; Eriksson BA; Samuelsson J
Article: BIOCHEMICAL PHARMACOLOGY. 1995;49(11):1577-1582
1-O-HEXADECYL-2-METOXY-GLYCERO-3-PHOSPHATIDYLCHOLINE - A METHOXY ETHER LIPID INHIBITING PLATELET-ACTIVATING FACTOR-INDUCED PLATELET-AGGREGATION AND NEUTROPHIL OXIDATIVE-METABOLISM
LEBLANC K; SAMUELSSON J; BROHULT J; BERG A; PALMBLAD J
Journal article: EUROPEAN JOURNAL OF HAEMATOLOGY. 1994;53(3):145-149
STIMULUS-SPECIFIC DEFECT IN PLATELET-AGGREGATION IN POLYCYTHEMIA-VERA
LEBLANC K; BERG A; PALMBLAD J; SAMUELSSON J
Visa fler

Alla övriga publikationer

Review: CELLULAR AND MOLECULAR IMMUNOLOGY. 2023;20(6):613-625
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
Kadri N; Amu S; Iacobaeus E; Boberg E; Le Blanc K
Editorial comment: CYTOTHERAPY. 2022;24(11):1071-1073
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry
Weiss DJ; Filiano A; Galipeau J; Khoury M; Krampera M; Lalu M; Le Blanc K; Nolta J; Phinney DG; Rocco PRM; Shi Y; Tarte K; Viswanathan S; Martin I
Review: CYTOTHERAPY. 2022;24(8):774-788
Proceedings of the ISCT scientific signature series symposium, "Advances in cell and gene therapies for lung diseases and critical illnesses" International Society for Cell & Gene Therapy, Burlington VT, US, July 16, 2021
Ting AE; Baker EK; Champagne J; Desai TJ; dos Santos CC; Heijink IH; Itescu S; Le Blanc K; Matthay MA; McAuley DF; McIntyre L; Mei SHJ; Parekkadan B; Rocco PRM; Sheridan J; Thebaud B; Weiss DJ
Review: CELL STEM CELL. 2021;28(10):1708-1725
Mesenchymal stromal cells: Putative microenvironmental modulators become cell therapy
Krampera M; Le Blanc K
Book chapter: HEMATOPOIETIC STEM CELL TRANSPLANTATION AND CELLULAR THERAPIES FOR AUTOIMMUNE DISEASES. 2021;p. 123-129
Mesenchymal Stromal Cell Therapy for Acute Graft Versus Host Disease—From Bench to Clinical Approval
Boberg E; Le Blanc K
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2021;27(2_SUPPL):356
Comprehensive phenotypic and functional analyses of peripheral blood monocytes during MS disease progression
Iacobaeus E; Kadri N; Gavin C; Le Blanc K
Preprint: SSRN ELECTRONIC JOURNAL. 2021
Mesenchymal Stromal Cells: Microenvironmental Modulators Become Cell Therapy
Le Blanc K; Krampera M
Letter: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2020;202(7):1051-1055
Five-Year Follow-up after Mesenchymal Stromal Cell-based Treatment of Severe Acute Respiratory Distress Syndrome
Simonson OE; Stahle E; Hansen T; Wedin JO; Larsson A; Mattsson M; Volchkov P; Le Blanc K; Rodin S; Grinnemo K-H
Editorial comment: STEM CELL RESEARCH AND THERAPY. 2020;11(1):235
Treatment of vocal fold scarring with autologous bone marrow-derived human mesenchymal stromal cells-first phase I/II human clinical study: commentary to response
Hertegard S; LeBlanc K
Letter: HAEMATOLOGICA. 2020;105(6):e310-e314
Mental fatigue after allogeneic hematopoietic stem cell transplantation is associated with cognitive dysfunction, but not central nervous system inflammation
Boberg E; Kadri N; Winterling J; Davies LC; Bjorklund A; Msghina M; Iacobaeus E; Le Blanc K
Conference publication: WOUND REPAIR AND REGENERATION. 2020;28(2):A4
DETERMINING THE EFFECTS OF BLOOD EXPOSURE ON MESENCHYMAL STROMAL CELL IMMUNOMODULATION
Gavin C; Forshell TP; Strom C; Tornqvist-Andren A; Le Blanc K; Davies L
Conference publication: WOUND REPAIR AND REGENERATION. 2020;28(2):A15
MESENCHYMAL STROMAL CELLS AS A NOVEL THERAPEUTIC FOR VOCAL FOLD SCARRING
Nagubothu SR; Hertegard S; Forshell TP; Strom C; Malmstrom E; Tolf A; Davies L; Le Blanc K
Conference publication: WOUND REPAIR AND REGENERATION. 2020;28(2):A17
DYSREGULATION OF WOUND HEALING IN THE ORAL MUCOSA IN CHRONIC GRAFT VERSUS HOST DISEASE - THE ROLE OF ORAL PROGENITOR CELLS
Davies L; Board-Davies E; Shamlou B; Tour G; Sloan A; Stephens P; Le Blanc K
Editorial comment: SCIENCE TRANSLATIONAL MEDICINE. 2019;11(480):eaat2189
Challenges for mesenchymal stromal cell therapies
Martin I; Galipeau J; Kessler C; Le Blanc K; Dazzi F
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2019;25:533-534
Immunological and clinical follow up after autologous bone-marrow mesenchymal stromal cell therapy in progressive multiple sclerosis: a phase I clinical study
Iacobaeus E; Kadri N; Lefsihane K; Boberg E; Gavin C; Lilja A; Brundin L; Le Blanc K
Letter: STEM CELLS AND DEVELOPMENT. 2018;27(24):1671-1673
Author Accountability in Biomedical Research
Caplan A; Badylak SF; Caplan AI; Davies LC; Stroemblad S; Weiss DJ; Le Blanc K
Letter: CYTOTHERAPY. 2018;20(5):755-758
Stromal progenitor cell modulation by thalidomide in the treatment of oral chronic graft-versus-host disease
Davies LC; Board-Davies E; Shamlou B; Boberg E; Garming-Legert K; Le Blanc K
Review: CYTOTHERAPY. 2018;20(3):273-278
MSCs-cells with many sides
Le Blanc K; Davies LC
Conference publication: VALUE IN HEALTH. 2017;20(9):A545-A546
SECOND-LINE TREATMENT FOR STEROID-REFRACTORY GRAFT-VERSUS-HOST DISEASE WITH MESENCHYMAL STROMAL CELLS. A CONCEPTUAL DISEASE MODEL
Thielen F; Blommestein HM; Oosten L; Fibbe W; Le Blanc K; Locatelli F; Sanchez-Guijo F; Calkoen F; Lankester A; Algeri M; Redondo-Guijo A; Uyl-de Groot CA
Editorial comment: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(6):861-862
Commentary: Role of Mesenchymal Stromal Cell-Mediated Crosstalk with Macrophages in Graft-versus-Host Disease and Tissue Repair
Davies LC; Boberg E; Le Blanc K
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):285
Thymic function predicts response to mesenchymal stromal cell treatment in chronic GVHD
Boberg E; von Bahr L; Heldring N; Afram G; Iacobaeus E; Modin C; Garming-Legert K; Ljungman P; Sugars R; Davies L; Kadri N; Le Blanc K
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):335
Functional shift of myeloid-derived suppressor cells during Multiple Sclerosis disease course
Iacobaeus E; Douagi I; Jitschin R; Andren AT; Gavin C; Lefsihane K; Davies L; Olsson T; Mougiakakos D; Kadri N; Le Blanc K
Conference publication: BLOOD. 2017;130
Thymic Function Predicts Response to Mesenchymal Stromal Cell Treatment in Chronic GvHD: A Phase II Clinical Study
Boberg E; Von Bahr L; Heldring N; Afram G; Iacobaeus E; Lindstrom C; Garming-Legert K; Ljungman P; Sugars R; Davies L; Kadri N; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2017;52:S234
The role of stromal dysfunction in oral chronic GVHD
Davies L; Boberg E; Board-Davies E; Shamlou B; Garming-Legert K; Le Blanc K
Conference publication: BLOOD. 2016;128(22):3374
Manufacturing of Mesenchymal Stromal Cells for the Treatment of Graft-Versus-Host Disease: A Survey within the European Society of Blood and Marrow Transplantation
Cristina T; Bernardo ME; Nagler A; Kuci S; Bornhauser M; Kohl U; Strunk D; Gaipa G; Introna M; Lazzari L; Apperley JF; Bukauskas A; Le Blanc K; Van Campenhout A; Beguin Y; Kuball J; van der Werf SM; de Elvira CR; Chabannon C; Roelofs H; Bonini C; Dazzi F
Letter: BONE MARROW TRANSPLANTATION. 2016;51(11):1518-1521
High incidence of severe chronic GvHD after HSCT with sibling donors. A single center analysis
Remberger M; Afram G; Sundin M; Uhlin M; LeBlanc K; Bjorklund A; Mattsson J; Ljungman P
Book chapter: TISSUE ENGINEERING AND REGENERATION IN DENTISTRY. 2016;p. 20-49
Immunomodulation by adult stem cells
Davies LC; Le Blanc K
Corrigendum: STEM CELLS TRANSLATIONAL MEDICINE. 2016;5(6):845
In Vivo Effects of Mesenchymal Stromal Cells in Two Patients With Severe Acute Respiratory Distress Syndrome (vol 4, pg 1199, 2015)
Simonson OE; Mougiakakos D; Heldring N; Bassi G; Johansson HJ; Dalen M; Jitschin R; Rodin S; Corbascio M; El Andaloussi S; Wiklander OPB; Nordin JZ; Skog J; Romain C; Koestler T; Hellgren-Johansson L; Schiller P; Joachimsson P-O; Hagglund H; Mattsson M; Lehtio J; Faridani OR; Sandberg R; Korsgren O; Krampera M; Weiss DJ; Grinnemo K-H; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S592
Treosulfan plus fludarabine - encouraging conditioning for allogeneic hematopoietic stem cell transplantation in multiple myeloma
Afram G; Nahi H; Liwing J; Heeg B; Mattsson J; LeBlanc K; Bjorkstrand B; Gahrton G; Ljungman P
Conference publication: MULTIPLE SCLEROSIS JOURNAL. 2016;22:155
Immunohistochemical characterization of mesenchymal perivascular stem/stromal cells in multiple sclerosis and healthy brain tissue
Iacobaeus E; Sugars RV; Tornqvist AA; Alm JJ; Alkass K; Druid H; Roytta M; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S371
High incidence of severe chronic GVHD after HSCT with sibling donors. An single center analysis
Remberger M; Aftram G; Sundin M; Uhlin M; LeBlanc K; Bjorklund A; Mattsson J; Ljungman P
Conference publication: BLOOD. 2015;126(23):2398
Phenotypic and Functional Alterations of Bone Marrow Mesenchymal Stem and Progenitor Cells in Chronic Myeloid Leukemia
Dolinska M; Klang J; Xiao P; Durgaryan A; Sandhow L; Johansson A-S; Kondo M; Deneberg S; Ungerstedt J; Le Blanc K; Stenke L; Ekblom M; Stromberg U; Mustjoki S; Lehmann S; Qian H
Letter: ORAL ONCOLOGY. 2015;51(12):e97-e99
Enhanced oral healing following local mesenchymal stromal cell therapy
Garming-Legert K; Tour G; Sugars R; von Bahr L; Davies LC; Le Blanc K
Review: HUMAN GENE THERAPY. 2015;26(8):506-517
Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles
Heldring N; Mager I; Wood MJA; Le Blanc K; Andaloussi SEL
Editorial comment: STEM CELLS INTERNATIONAL. 2015;2015:280572-2
MSCs: Scientific Support for Multiple Therapies
Pittenger MF; Le Blanc K; Phinney DG; Chan JKY
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S403-S404
Increased incidence of CMV disease in patients with vitamin D deficiency before allogeneic stem cell transplantation
Von Bahr L; Blennow O; Bjorklund A; Malmberg K-J; Ljungman P; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S361
Which unrelated donor should I choose?
Remberger M; Mattsson J; Hauzenberger D; LeBlanc K; Sundin K; Schaffer M; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S185
Immunogenicity of virosomal adjuvanted trivalent influenza vaccination in allogeneic stem cell transplant recipients
Ambati A; Einarsdottir S; Magalhaes I; Poiret T; Bodenstein R; LeBlanc K; Brune M; Maeurer M; Ljungman P
Conference publication: NEONATOLOGY. 2015;107(4):381
Safety Aspects of Intravenous Mesenchymal Stem Cell Transplantation in Preterm Infants
Henckel E; Gotherstrom C; Le Blanc K; Hallberg B; Bohlin K
Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S298
VITAMIN D DEFICIENCY AND COMPLICATIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
Von Bahr L; Alm J; Malmberg K-J; Bjorklund A; Labopin M; Ljungman P; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S161-S162
LONG-TERM FOLLOW UP OF BONE DENSITY AND REPRODUCTIVE HEALTH IN FEMALE SURVIVORS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
Naessen S; Bergstrom I; Leblanc K; Ljungman P; Landgren B-M
Book chapter: TISSUE ENGINEERING. 2014;p. 427-469
Chapter 13 Clinical Grade Production of Mesenchymal Stromal Cells
Alm JJ; Qian H; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S187-S188
FLUDARABINE AND TREOSULPHAN IS AN EFFECTIVE CONDITIONING REGIMEN FOR ADULT PATIENTS WITH MDS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
Ljungman P; LeBlanc K; Engstrom M; Jadersten M; Reykdal S; Mattsson J; Remberger M; Hellstrom-Lindberg E
Thesis / dissertation: 2013
Engineering more efficient multipotent mesenchymal stromal (stem) cells for systemic delivery as cellular therapy
Moll, Guido
Letter: NATURE MEDICINE. 2013;19(7):812-813
MSCs: science and trials
Fibbe WE; Dazzi F; LeBlanc K
Conference publication: HAEMATOLOGICA. 2013;98:152
VITAMIN D DEFICIENCY INCREASES THE RISK OF COMPLICATIONS IN ALLOGENEIC STEM CELL TRANSPLANTATIONS
Von Bahr L; Alm J; Moll G; Jitschin R; Bjorklund A; Malmberg K; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S81-S82
Does freeze-thawing of therapeutic mesenchymal stromal cells affect their efficacy as immunosuppressive treatment?
von Bahr L; Moll G; Le Blanc K
Book chapter: MESENCHYMAL STROMAL CELLS: STEM CELL BIOLOGY AND REGENERATIVE MEDICINE. 2013;p. 455-465
MSCs for Graft-Versus-Host Disease
Tolar J; Le Blanc K; Blazar BR
Conference publication: BONE MARROW TRANSPLANTATION. 2013;48:S73
Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic haematopoietic stem cell transplantation
Jitschin R; Mougiakakos D; Linder S; von Bahr L; Moll G; Voelkl S; Kiessling R; Ringden O; Le Blanc K
Review: NATURE REVIEWS IMMUNOLOGY. 2012;12(5):383-396
Multipotent mesenchymal stromal cells and the innate immune system
Le Blanc K; Mougiakakos D
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2012;18(2):S335
A PROSPECTIVE RANDOMIZED STUDY COMPARING REDUCED-INTENSITY CONDITIONING AND MYELOABLATIVE CONDITIONING IN PATIENTS WITH MYELOID LEUKEMIA UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Ringden O; Erkers T; Aschan J; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Ljungman P; Mattsson J; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2012;47:S416
A prospective randomised study comparing reduced-intensity conditioning and myeloablative conditioning in patients with myeloid leukaemia undergoing allogeneic haematopoietic stem cell transplantation
Ringden O; Erkers T; Aschan J; Le Blanc K; Hagglund H; Omazic B; Svenberg P; Ljungman P; Mattsson J; Remberger M
Conference publication: JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE. 2012;6:285
Keynote: Immunomodulation by mesenchymal stem cells
Le Blanc K
Letter: BONE MARROW TRANSPLANTATION. 2011;46(8):1158-1160
Pooled MSCs for treatment of severe hemorrhage
Ringden O; LeBlanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S369
Is there a graft-versus-MDS effect after haematopoietic allogeneic stem cell transplantation?
Remberger M; Mattsson J; Hassan Z; Hagglund H; Le Blanc K; Machaczka M; Olsson R; Omazic B; Svenberg P; Hellstrom-Lindberg E; Ljungman P; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S167-S168
Improved survival after allogeneic haematopoietic stem cell transplantation in recent years
Ringden O; Ackefors M; Berglund S; Blennow O; Dahllof G; Dlugosz A; Garming-Legert K; Gertow J; Gustafsson B; Hassan M; Hassan Z; Hauzenberger D; Hagglund H; Karlsson H; Klingspor L; Kumlien G; Le Blanc K; Ljungman P; Machaczka M; Marschall H-U; Mattsson J; Olsson R; Omazic B; Sairafi D; Schaffer M; Svahn B-M; Svenberg P; Swartling L; Szakos A; Uhlin M; Uzunel M; Watz E; Wernerson A; Wikman A; Wikstrom A-C; Winiarski J; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S6-S7
Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children
Ball LM; Bernardo ME; van Tol MJD; Giorgiani G; Roelofs H; Cometa AM; Bertaina A; Zwaginga JJ; van de Zijde EJ; Avanzini MA; Le Blanc K; Ringden O; Frassoni F; Fibbe WE; Egeler M; Lankester AC; Locatelli F
Review: STEM CELLS. 2010;28(8):1446-1455
Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells
Tolar J; Le Blanc K; Keating A; Blazar BR
Review: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2010;161(2):223-232
Immunotherapy prospects for acute myeloid leukaemia
Barrett AJ; Le Blanc K
Letter: VOX SANGUINIS. 2010;98(3):e364-e365
Photochemical pathogen inactivation of human serum enables its large-scale application in clinical cell transplantation
Stahle M; Carlsson B; Le Blanc K; Korsgren O; Knutson F
Review: MULTIPLE SCLEROSIS JOURNAL. 2010;16(4):503-510
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group
Freedman MS; Bar-Or A; Atkins HL; Karussis D; Frassoni F; Lazarus H; Scolding N; Slavin S; Le Blanc K; Uccelli A
Conference publication: BLOOD. 2010;116(21):965
Early Intervention with Mesenchymal Stromal Cells for Refractory Grade III-IV Graft Versus Host Disease In Children Results In Excellent Long Term Outcome.
Ball LM; Bernardo ME; Zwaginga JJ; van Tol M; Cometa A; Roelofs H; Giorgiani G; Jol-van der Zijde CM; Avanzini MA; Le Blanc K; Bertaina A; Frassoni F; Fibbe WE; Ringden O; Egeler RM; Locatelli F; Lankester A
Conference publication: BONE MARROW TRANSPLANTATION. 2010;45:S261
Children responding to treatment with mesenchymal stromal cells for refractory severe graft-versus-host disease have excellent long-term outcome
Ball LM; Bernardo ME; van Tol MJD; Avanzini MA; Lankester AC; Roelofs H; Giorgiani G; Zwaginga JJ; Le Blanc K; Fibbe WE; Egeler RM; Locatelli F
Conference publication: BLOOD. 2010;116(21):1578
Human Embryonic Stem Cell-Derived Mesenchymal Stroma Cells (hES-MSC) Share Basic Properties with Bone Marrow MSC, They Have Potent Stroma Support Capacities but Lack Immune-Modulatory Function. Implications for off-the Shelf ES-MSC Therapies
Li O; Tormin A; Brune JC; Sundberg B; Hyllner J; Le Blanc K; Scheding S
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):12-13
LYMPHOCYTE RECOVERY IS A MAJOR DETERMINANT OF TRANSPLANT OUTCOME AFTER MYELOABLATIVE TRANSPLANTATION IN PATIENTS WITH MYELOID MALIGNANCIES RECEIVING MATCHED UNRELATED STEM CELL ALLOGRAFTS
Le Blanc K; Remberger M; Barrett J
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2009;15(2):47
HLA MISMATCHED MSC SUPPRESS T LYMPHOCYTE ALLORESPONSES IN VITRO AND DO NOT INDUCE IMMUNOLOGICAL MEMORY IN RECIPIENTS OF MSC INFUSION
Sundin M; Barrett J; Ringden O; Uzunel M; Lonnies H; Dackland A-L; Christensson B; Le Blanc K
Editorial comment: CYTOTHERAPY. 2009;11(2):245-255
Basic research and clinical applications of non-hematopoietic stem cells, 4-5 April 2008, Tubingen, Germany
Schaefer R; Dominici M; Mueller I; Horwitz E; Asahara T; Bulte JWM; Bieback K; Le Blanc K; Buehring HJ; Capogrossi MC; Dazzi F; Gorodetsky R; Henschler R; Handgretinger R; Kajstura J; Kluger PJ; Lange C; von Luettichau I; Mertsching H; Schrezenmeier H; Sievert KD; Strunk D; Verfaillie C; Northoff H
Conference publication: BONE MARROW TRANSPLANTATION. 2009;43:S241-S242
CMV infection and disease after allogeneic stem cell transplantation with reduced-intensity conditioning
Avetisyan G; Hagglund H; Hassan Z; LeBlanc K; Mattsson J; Ringden O; Winiarski J; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 2009;43:S188
SCT recipients have specific tolerance to MSC but not to the MSC donor
Sundin M; Barrett J; Ringden O; Uzunel M; Lonnies H; Dackland A; Christensson B; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2009;43:S161-S162
Complement compatibility of human mesenchymal stem cells during clinical infusion into whole blood for treatment of graft-versus-host disease
Moll G; Rasmusson I; Elgue G; Sundberg B; Ekdahl KN; Le Blanc K; Nilsson B
Meeting abstract: MOLECULAR IMMUNOLOGY. 2008;45(16):4118
Complement activation triggered by human mesenchymal stem cells intended for clinical use
Moll G; Rasmusson I; Sundberg B; Ekdahl KN; LeBlanc K; Nilsson B
Letter: THE LANCET. 2008;372(9640):716
Mesenchymal stem cells for acute graft-versus-host disease -: Reply
Le Blanc K; Fibbe W; Frassoni F; Locatelli F; Ringden O
Letter: BONE MARROW TRANSPLANTATION. 2008;41(3):319
A new cell therapy registry coordinated by the European Group for Blood and Marrow Transplantation (EBMT)
Le Blanc K; Fibbe W
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2008;14(2):48-49
MESENCHYMAL STEM CELLS EXERT DIFFERENTIAL EFFECTS ON ALLO-ANTIGEN- AND VIRUS-SPECIFIC T CELLS
Karlsson H; Samarasinghe S; Ball L; Sundberg B; Lankester AC; Dazzi F; Rao K; Veys P; Le Blanc K; Ringden O; Amrolia PJ
Editorial comment: CYTOTHERAPY. 2008;10(5):441-442
Lymphocyte recovery: an overlooked contribution to autologous stem cell transplant outcome
Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S60
EBV associated PTLD after allogeneic stem cell transplant patients
Omar H; Hagglund H; Gustafsson-Jernberg A; Le Blanc K; Mattsson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S15-S16
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses
Karlsson H; Samarasinghe S; Ball L; Sundberg B; Lankester AC; Dazzi F; Rao K; Veys P; Le Blanc K; Ringden O; Amrolia PJ
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S322
Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen:: implications for transplantation
Sundin M; Lindblom A; Oervell C; Barrett J; Sundberg B; Watz E; Wikman A; Broliden K; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S11-S12
Lymphocyte recovery is a major determinant of transplant outcome after myeloablative transplantation in patients with myeloid malignancies receiving matched unrelated grafts
Le Blanc K; Remberger M; Barrett J
Conference publication: BONE MARROW TRANSPLANTATION. 2008;41:S214
Mesenchymal stem cells for treatment of severe, refractory acute graft-versus-host disease
Le Blanc K; Frassoni F; Ball L; Locatelli F; Roelofs H; Lewis I; Lanino E; Sundberg B; Bernardo M; Remberger M; Dini G; Egeler M; Bacigalupo A; Fibbe W; Ringden O
Meeting abstract: BLOOD. 2007;110(11):2969-872A
Prospecitve quantitative PCR monitoring of allogeneic stem cell transplant (SCT) patients at high risk for EBV associated PTLD
Omar H; Hagglund H; Gustafsson-Jernberg A; Le Blanc K; Mattson J; Remberger M; Ringden O; Sparrelid E; Sundin M; Winiarski JH; Yun Z; Ljungman PT
Review: JOURNAL OF INTERNAL MEDICINE. 2007;262(5):509-525
Immunomodulation by mesenchymal stem cells and clinical experience
Le Blanc K; Ringden O
Conference publication: HUMAN IMMUNOLOGY. 2007;68:S22
HLA antibodies produced after rejection of kidney transplants
Lavingia B; Comeaux A; Rogers J; LeBlanc K; Arenas J; Lu C; Vazquez M; Stastny P
Review: STEM CELLS. 2007;25(3):707-711
Concise review: Cancer/testis antigens, stem cells, and cancer
Costa FF; Le Blanc K; Brodin B
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):47
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon
Ringden O; Uzunel M; Sundberg B; Lonnies L; Nava S; Gotherstrom C; Gustafsson J; Henningsohn L; Le Blanc K
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2007;13(2):46
Co-transplantation of mesenchymal stem cells and hematopoietic stem cells
Le Blanc K; Sundberg B; Lonnies H; Aschan J; Barkbolt L; Gustafsson B; Ringden O
Editorial comment: CYTOTHERAPY. 2007;9(4):397-405
Progress in characterization, preparation and clinical applications of non-hematopoietic stem cells, 29-30 September 2006, Tubingen, Germany -: Meeting report
Schaefer R; Dominici M; Mueller I; Dazzi F; Bieback K; Godthardt K; Le Blanc K; Meisel R; Pochampally R; Richter R; Skutella T; Steinhoff G; Mitterberger M; Wendel HP; Wiskirchen J; Handgretinger R; Northoff H
Editorial comment: ARTHRITIS RESEARCH & THERAPY. 2007;9(1):301
Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005
Tyndall A; Walker UA; Cope A; Dazzi F; De Bari C; Fibbe W; Guiducci S; Jones S; Jorgensen C; Le Blanc K; Luyten F; McGonagle D; Martin I; Bocelli-Tyndall C; Pennesi G; Pistoia V; Pitzalis C; Uccelli A; Wulffraat N; Feldmann M
Conference publication: BONE MARROW TRANSPLANTATION. 2007;39:S219
Tissue repair using allogeneic mesenchymal stem cells for haemorrhagic cystitis, pneumomediastinum and perforated colon
Ringden O; Uzunel M; Sundberg B; Lonnies L; Nava S; Gustafsson J; Henningsohn L; Le Blanc K
Conference publication: XENOTRANSPLANTATION. 2007;14(5):426-427
Mesenchymal stem cells (MSCs) in immunotherapy
Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2007;39:S52
Co-transplantation of parental mesenchymal stem cells to improve outcome of cord blood transplantation in children
Bernardo ME; Ball L; Cometa A; Zecca M; Giorgiani G; Maccario R; Barberi W; Comoli P; Bonetti F; Le Blanc K; Roelofs H; Egeler M; Fibbe W; Locatelli F
Book chapter: CELLULAR TRANSPLANTATION. 2007;p. 241-257
13 Stem Cell Transplantation for Autoimmune Diseases
Tyndall A; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2007;39:S27
Mesenchymal stem cells for treatment of severe acute graft-versus-host disease
Le Blanc K; Frassoni F; Ball L; Locatelli F; Lewis I; Lanino E; Sundberg B; Roelofs H; Lonnies L; Dini G; Bacigalupo A; Fibbe W; Ringden O
Review: CURRENT OPINION IN IMMUNOLOGY. 2006;18(5):586-591
Mesenchymal stem cells:: properties and role in clinical bone marrow transplantation
Le Blanc K; Ringden O
Letter: BONE MARROW TRANSPLANTATION. 2006;38(4):321-322
Myeloablative conditioning for hematopoietic stem cell transplantation in patients with non-malignant diseases
Ringden O; Svenberg P; Le Blanc K; Mattsson J; Remberger M
Book chapter: STEM CELL TRANSPLANTATION. 2006;p. 233-245
Immune Escape and Suppression by Human Mesenchymal Stem Cells
Le Blanc K; Ringdén O
Letter: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(6):693-694
Mesenchymal stem cells combined with cyclosporine inhibits cytotoxic T cells
Ringdén O; Le Blanc K
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2006;12(2):2
Mesenchymal stem cells for treatment of severe acute graft-versus-host disease
Ringden O; Uzunel M; Rasmusson I; Remberger ME; Sundberg B; Lonnies H; Marschall HU; Dlugosz A; Szakos A; Hassan Z; Omazic B; Aschan J; Barkholt L; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2006;37:S104
Factors associated with relapse in patients with chronic graft-versus-host disease after allogeneic stem cell transplantation
Remberger M; Aschan J; Barkholt L; Hassan Z; LeBlanc K; Mattsson J; Omazik B; Ljungman P; Ringdén O
Conference publication: BONE MARROW TRANSPLANTATION. 2006;37:S1
Mesenchymal stem cells for treatment of severe acute and extensive chronic graft-versus-host disease
Ringden O; Frassoni F; Uzunel M; Lanino E; Sundberg B; Lonnies H; Dini G; Bacigalupo A; Locatelli F; Fibbe W; Le Blanc K
Conference publication: CYTOTHERAPY. 2006;8
Herpesviruses in mesenchymal stem cells.
Sundin M; Orvell C; Rasmusson I; Sundberg B; Ringden O; LeBlanc K
Conference publication: CYTOTHERAPY. 2006;8
Differences between human fetal and adult multipotent mesenchymal stromal cells (MSC) concerning NK-cell lysis.
Gotherstrom C; Rasmusson I; Le Blanc K
Conference publication: BLOOD. 2006;108(11):226A
Mesenchymal stem cells for treatment of severe acute graft-versus-host disease.
Le Blanc K; Frassoni F; Ball L; Lanino E; Sundberg B; Lonnies L; Roelofs H; Dini G; Bacigalupo A; Locatelli F; Fibbe WF; Ringden O
Conference publication: EXPERIMENTAL HEMATOLOGY. 2006;34(9):65
Mesenchymal stem cells (MSCS) in immunotherapy
Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2006;37:S151
Co-transplantation of haploidentical bone marrow-derived mesenchymal stem cells and haematopoietic stem cells to promote engraftment in children.: A phase I/II multicentre study
Ball LM; Le Blanc K; Roelofs H; Lankester A; Egeler RM; Frassoni F; Ringdén O; Fibbe WE
Conference publication: CYTOTHERAPY. 2006;8
Optimized in vitro conditions for immunomodulation by adult mesenchymal stem cells.
Ringden O; Lonnies L; Le Blanc K
Conference publication: CYTOTHERAPY. 2006;8
Co-transplantation of haplo-identical bone marrow-derived mesenchymal stem cells and hematopoietic stem cells to promote engraftment in children.: A phase I/II multicenter study.
Ball LM; LeBlanc K; Roelofs H; Lankester AC; Egeler M; Frassoni F; Ringden O; Fibbe WE
Conference publication: ANNALS OF ONCOLOGY. 2006;17:25-26
Mesenchymal stem cells (MSCS) in immunotherapy
Le Blanc K
Review: APMIS. 2005;113(11-12):813-830
Allogeneic hematopoietic stem cell transplantation:: state of the art and new perspectives
Ringdén O; Le Blanc K
Review: EXPERIMENTAL HEMATOLOGY. 2005;33(5):505-512
Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts:: Uses, misuses, misconceptions, and future applications
Ringdén OTH; Le Blanc K; Remberger M
Review: TRANSPLANTATION AND CELLULAR THERAPY. 2005;11(5):321-334
Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation
Le Blanc K; Ringdén O
Other: HAEMATOLOGICA. 2005;90(4):438
Use of mesenchymal stem cells for the prevention of immune complications of hematopoietic stem cell transplantation.
Le Blanc K; Ringdén O
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2005;11(2):69-70
Human mesenchymal stem cells affect IgG production induced by lipopolysaccharide, cytomegalovirus and varicella zoster virus in human spleen
Rasmusson I; Sundberg B; Le Blanc K; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2005;35:S267
Allogeneic haematopoietic stem cell transplantation for metabolic disorders, a single-centre experience
Ringden O; Remberger M; Svahn B; Barkholt L; Aschan J; Mattsson J; Le Blanc K; Gustafsson B; Hassan Z; Svenberg P; Solders G; von Dobeln U; Winiarski J; Ljungman P; Malm G
Conference publication: BONE MARROW TRANSPLANTATION. 2005;35:S145-S146
Cyclosporine A (CsA) 2 hour-concentration after oral intake varies between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
Barkholt L; Böttiger Y; Bodegård H; Elbander M; Aschan J; Hassan Z; LeBlanc K; Mattsson J; Ringdén O
Conference publication: BLOOD. 2005;106(11):45A
Mesenchymal stem cells for treatment of severe acute and extensive chronic graft-versus-host disease.
Le Blanc K; Frassoni F; Ball L; Uzunel M; Lanini E; Sundberg B; Lonnies H; Dini G; Bacigalupo A; Locatelli F; Fibbe WE; Ringden OTH
Conference publication: BLOOD. 2005;106(11):817A
Transplantation of haplo-identical bone marrow-derived mesenchymal stem cells together with hematopoietic stem cells to promote engraftment in children -: A phase I/II multicenter study
van Velzen-Ball LM; Le Blanc K; Lankester AC; Roelofs H; Egeler M; Frassoni F; Ringdén O; Fibbe WE
Conference publication: EUROPEAN HEART JOURNAL. 2005;26:685
Human mesenchymal stem cells do not differentiate into cardiac myocytes in ischaemic myocardium
Grinnemo KH; Mansson-Broberg A; LeBlanc K; Siddiqui AJ; Hao X; Sylven C; Dellgren G
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2004;10(2):17
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
Conference publication: BLOOD. 2004;104(11):147A
Mesenchymal stem cell engraftment in bone following in utero transplantation in a patient with severe osteogenesis imperfecta.
Le Blanc K; Götherström C; Ringdén O; Hassan M; McMahon R; Horwitz E; Anneren G; Axelsson O; Nunn J; Ewald U; Nordén-Lindeberg S; Jansson M; Dalton A; Åström E; Westgren M
Conference publication: INTERNATIONAL JOURNAL OF OBESITY. 2004;28:S11
Human mesenchymal stem cells as a renewable source of adipocytes
Rydén M; Dicker A; Aström G; Le Blanc K; Arner P
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S185
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
Le Blanc K; Rasmusson I; Sundberg B; Götherström C; Hassan M; Uzunel M; Ringdén O
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S88-S89
Immunological properties of human foetal mesenchymal stem cells
Götherström C; Ringdén O; Tammik C; Zetterberg E; Westgren M; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S87
Human mesenchymal stem cells increase interleukin-2 and soluble IL-2 receptor in mixed lymphocyte cultures
Rasmusson I; Ringdén O; Sundberg B; Lönnies L; Le Blanc K
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S131-S132
Which donor should be chosen for haematopoietic stem cell transplantation among unrelated HLA-A, -B and -DRB1 genomically identical volunteers?
Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi M; Olerup O; Ljungman P; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S38
A comparison of non-myeloablative versus reduced conditioning for allogeneic stem cell transplantation
Ringdén O; Le Blanc K; Uzunel M; Mattsson J; Barkholt L; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S187
Graft-versus-host disease is associated with a lower relapse incidence after haematopoietic stem cell transplantation in patients with acute lymphoblastic leukaemia
Nordlander A; Mattsson J; Ringden O; Le Blanc K; Gustavsson B; Ljungman P; Svenberg P; Svennilson J; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2004;33:S86
Mesenchymal stem cells inhibit the expression of IL-2 receptor (CD25) and CD38 on phytohemagglutinin-activated lymphocytes
Le Blanc K; Rasmusson I; Götherström C; Seidel C; Sundberg B; Rosendahl K; Tammik C; Ringdén O
Meeting abstract: AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. 2003;189(6):s215
Donor chimerism across full allogenic barriers achieved by in utero transplantation of fetal mesenchymal stem cells in a case of osteogenesis imperfecta
Westgren L; Anneren G; Axelsson O; Evald U; Leblanc K; Ringden O
Editorial comment: TRANSPLANTATION. 2003;76(7):1011-1012
Transplantation of embryonic stem cells:: Possibilities and challenges
Ringdén O; Le Blanc K; Hovatta O
Conference publication: BONE MARROW TRANSPLANTATION. 2003;31:S246
Mesenchymal stem cells inhibit mixed lymphocyte culture but not cell-mediated lympholysis
Le Blanc K; Rasmusson I; Sundberg B; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2003;31:S244-S245
HLA expression and immunologic properties of differentiated and undifferentiated adult and fetal mesenchymal stem cells
Le Blanc K; Götherström C; Tammik C; Ringden O
Conference publication: BONE MARROW TRANSPLANTATION. 2003;31:S176
A low body mass index is correlated to poor survival after allogeneic stem cell transplantation
Le Blanc K; Ringdén O; Remberger M
Conference publication: BONE MARROW TRANSPLANTATION. 2003;31:S149-S150
Infections after low-intensity conditioning for allogeneic blood stem cell transplantation in metastatic solid tumors
Barkholt L; Blomkvist M; Hentschke P; Klingspor L; Lewensohn-Fuchs I; LeBlanc K; Milosavljevic R; Pisa P; Remberger M; Svenberg P; Thörne A; Wersäll P; Ringdén O
Conference publication: BONE MARROW TRANSPLANTATION. 2003;31:S4
Increased risk of graft-versus-host disease and transplant-related mortality using granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia
Ringden O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet J; Cordonnier C; Frassoni F
Review: LAKARTIDNINGEN. 2002;99(12):1318-1324
[Mesenchymal stem cells. Basic science and future clinical use].
Le Blanc K
Conference publication: BLOOD. 2001;98(11):318B
Inhibition or enhancement of mixed lymphocyte cultures by allogeneic and autologous mesenchymal stem cells is dependent on cell dose.
Le Blanc K; Tammik C; Sundberg B; Ringden O
Conference publication: BLOOD. 2001;98(11):105A-106A
Down-regulation of IMP-dehydrogenase and depletion of guanine ribonucleotides serve as metabolic signals for myeloid cell development.
Wright DG; Le Blanc K; Boosalis M; Heckathorne R
Thesis / dissertation: 1999
Platelet function in polycythemia vera : studies of agonist and cytokine induced platelet activation
Le Blanc, Katarina
Conference publication: THROMBOSIS AND HAEMOSTASIS. 1999;:153
Marked heterogeneity in protein levels and functional integrity of the thrombopoietin receptor c-mpl in polycythemia vera
Le Blanc K; Samuelsson J
Published conference paper: THROMBOSIS RESEARCH. 1998;91(6):287-295
Impaired platelet binding of fibrinogen due to a lower number of GPIIB/IIIA receptors in polycythemia vera
Le Blanc K; Lindahl T; Rosendahl K; Samuelsson J
Conference publication: BLOOD. 1998;92(10):426A
Defective platelet aggregation in polycythemia vera is not caused by impaired calcium signalling, phospholipase D activation or decreased amounts of FAK, SYK or rhoA.
Le Blanc K; Samuelsson J
Conference publication: BLOOD. 1997;90(10):4055
mRNA expression as well as protein levels of hematopoietic cell phosphatase are normal in both bone marrow CD34+ bone marrow progenitor cells and mature peripheral blood cells in polycythemia vera.
Andersson P; LeBlanc K; Eriksson BA; Samuelsson J
Letter: EUROPEAN JOURNAL OF HAEMATOLOGY. 1996;57(3):257-258
Elevated plasma lipoprotein (a) - A potential risk factor for thromboembolic complications in polycythaemia vera
LeBlanc K; Samuelsson J
Conference publication: BLOOD. 1996;88(10):3568
Elevated plasma lipoprotein (a) - A potential risk factor for thrombembolic complications in polycythemia vera.
Samuelsson J; LeBlanc K
Conference publication: BRITISH JOURNAL OF HAEMATOLOGY. 1996;93:625
Impaired activation of the fibrinogen receptor on polycythemia vera platelets after platelet activating factor stimulation
LeBlanc K; Lindahl T; Rosendahl K; Samuelsson J
Visa fler

Forskningsbidrag

Stromal dysfunction and neuroinflammation - experimental and clinical studies
Swedish Research Council
1 January 2023 - 31 December 2026
Stromal dysfunction and neurodegeneration in chronic graft versus host disease - experimental and clinical studies
Swedish Research Council
1 January 2019 - 31 December 2022
Experimental and clinical studies of mesenchymal stem cell immune properties
Swedish Cancer Society
1 January 2015
Elucidating the etiology of type I diabetes and development of cellular therapeutic interventions to halt or reverse the disease.
Swedish Research Council
1 January 2015 - 31 December 2018
Strategies for stem cell survival
Swedish Foundation for Strategic Research
1 July 2014 - 30 June 2019
Experimental and clinical studies of mesenchymal stem cell immune impairment
Swedish Cancer Society
1 January 2014
Experimental and clinical studies of the interaction between mesenchymal stem cells and innate and adaptive immunity as treatment of immune mediated disorders
Swedish Research Council
1 January 2014 - 31 December 2018
Stem cell therapy to treat severe osteogenesis imperfecta.
Swedish Research Council
1 January 2014 - 31 December 2017
Cellular interventions and beta-cell replacement therapies in type 1 diabetes: a nationwide approach to develop the next generation therapies
Swedish Research Council
1 January 2014 - 31 December 2017
Clinical application of bioengineered organs with special emphasis to the trachea
Swedish Research Council
1 January 2013 - 31 December 2017
Means to monitor, preserve and restore beta-cell mass in type 1 diabetes mellitus
Swedish Research Council
1 January 2013 - 31 December 2017
Use of ex vivo expanded natural killer cells as a treatment strategy for hematological malignancies with special emphasis on multiple myeloma
Swedish Research Council
1 January 2012 - 31 December 2014
Oral mucosal lamina propria progenitor cells as a novel and preferential source for treatment of Graft Vs Host Disease
Medical Research Council
31 March 2011 - 14 May 2014
Oral mucosal lamina propria progenitor cells as a novel and preferential source for treatment of Graft Vs Host Disease
Medical Research Council
31 March 2011 - 14 May 2014
Cell therapies
VINNOVA
18 January 2011 - 31 December 2016
Reconstruction of vocal fold scarring with mesenchymal stem cell therapy
Swedish Research Council
1 January 2011 - 31 December 2012
Experimental and clinical studies of interaction between mesenchymal stem cells and innate and adaptive immunity to improve the outcome of allogeneic stem cell transplantation.
Swedish Research Council
1 January 2011 - 31 December 2013
Development of a human embryonic and mesenchymal stem cell therapy for Parkinsons disease
Swedish Research Council
1 January 2009 - 31 December 2011

Anställningar

Professor/Specialistläkare, Laboratoriemedicin, Karolinska Institutet, 2007-

Examina och utbildning

Docent, Hematologi, Karolinska Institutet, 2004
MEDICINE DOKTORSEXAMEN, Institutionen för medicin, Huddinge, Karolinska Institutet, 1999
Läkarexamen, Karolinska Institutet, 1993

Om mig

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI